The value placed on biotechnology companies has soared, but are their chances of success any better?
The man who took over stewardship of Bitcoin from its mysterious inventor says the currency is in serious trouble.
A startup company says it is expanding the language of DNA to create new tools for drug discovery.
SolarCity’s massive new manufacturing plant in Buffalo, New York, reflects a booming demand for solar power. Is it sustainable?
Investors see riches in a cryptography-enabled technology called smart contracts–but it could also offer much to criminals.
Google’s new structure has few historical precedents, in tech or outside it.
Deep inside its labs, Monsanto is learning how to modify crops by spraying them with RNA rather than tinkering with their genes.
A company started by several gene-editing pioneers gets new funding to develop treatments for blood cancers, eye diseases, and sickle-cell anemia.
A security researcher has worked out more than a dozen ways to remotely wreck the guts of industrial facilities.
A reincarnation of one of the oldest ideas in artificial intelligence could finally make it possible to truly converse with our computers. And Facebook has a chance to make it happen first.